Ottavio Valerio Vitolo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methadone | 3 | 2019 | 306 | 1.300 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2019 | 895 | 1.050 |
Why?
|
| Antidepressive Agents | 6 | 2021 | 2838 | 0.550 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 365 | 0.540 |
Why?
|
| Drug Evaluation | 1 | 2016 | 647 | 0.490 |
Why?
|
| Ginkgolides | 1 | 2007 | 4 | 0.310 |
Why?
|
| Synaptic Transmission | 3 | 2007 | 1178 | 0.280 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6489 | 0.270 |
Why?
|
| Amyloid beta-Peptides | 4 | 2007 | 3587 | 0.260 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2006 | 514 | 0.260 |
Why?
|
| Lactones | 1 | 2007 | 329 | 0.250 |
Why?
|
| Depression | 2 | 2019 | 7766 | 0.200 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2006 | 491 | 0.200 |
Why?
|
| Alzheimer Disease | 6 | 2016 | 8037 | 0.200 |
Why?
|
| Depressive Disorder, Major | 5 | 2021 | 4644 | 0.200 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2000 | 170 | 0.180 |
Why?
|
| Peptide Fragments | 3 | 2007 | 5097 | 0.180 |
Why?
|
| Cyclic AMP | 2 | 2006 | 1472 | 0.170 |
Why?
|
| Apoptosis | 4 | 2007 | 9727 | 0.170 |
Why?
|
| Swimming | 1 | 2019 | 206 | 0.160 |
Why?
|
| Dendritic Spines | 3 | 2019 | 233 | 0.160 |
Why?
|
| Synapses | 1 | 2007 | 1728 | 0.150 |
Why?
|
| Adenosine Diphosphate | 1 | 1998 | 425 | 0.150 |
Why?
|
| Ketamine | 2 | 2019 | 500 | 0.140 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2017 | 197 | 0.140 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2006 | 1121 | 0.130 |
Why?
|
| Neurons | 5 | 2007 | 9338 | 0.130 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12026 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 8301 | 0.120 |
Why?
|
| Hippocampus | 6 | 2006 | 3675 | 0.120 |
Why?
|
| Adenosine | 1 | 1998 | 825 | 0.120 |
Why?
|
| Rats | 7 | 2019 | 24260 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 1414 | 0.110 |
Why?
|
| Carnitine | 1 | 2014 | 246 | 0.110 |
Why?
|
| S-Adenosylmethionine | 1 | 2014 | 212 | 0.110 |
Why?
|
| Libido | 1 | 2013 | 121 | 0.110 |
Why?
|
| Cerebellum | 2 | 2000 | 1488 | 0.110 |
Why?
|
| Histamine | 1 | 2014 | 507 | 0.110 |
Why?
|
| Piperazines | 2 | 2013 | 2488 | 0.100 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2016 | 584 | 0.100 |
Why?
|
| Quinolines | 1 | 2017 | 732 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 2418 | 0.100 |
Why?
|
| Citalopram | 1 | 2014 | 403 | 0.100 |
Why?
|
| Long-Term Potentiation | 4 | 2006 | 293 | 0.090 |
Why?
|
| Sulfones | 1 | 2013 | 437 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 1738 | 0.090 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 605 | 0.090 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2013 | 360 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2017 | 1058 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 2147 | 0.080 |
Why?
|
| Rolipram | 2 | 2006 | 27 | 0.080 |
Why?
|
| Memory | 2 | 2010 | 2174 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2002 | 9438 | 0.080 |
Why?
|
| Cognition Disorders | 2 | 2020 | 4043 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10943 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2006 | 215 | 0.070 |
Why?
|
| Pyramidal Cells | 2 | 2006 | 363 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2017 | 1972 | 0.070 |
Why?
|
| PC12 Cells | 3 | 2002 | 330 | 0.070 |
Why?
|
| Thiazoles | 1 | 2012 | 1483 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2007 | 19229 | 0.060 |
Why?
|
| Animals | 15 | 2019 | 168757 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2005 | 409 | 0.060 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2013 | 1004 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 449 | 0.060 |
Why?
|
| Students | 1 | 2013 | 1654 | 0.060 |
Why?
|
| Sympatholytics | 1 | 2002 | 83 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2013 | 2057 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2019 | 377 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2010 | 1184 | 0.050 |
Why?
|
| Male | 13 | 2023 | 350118 | 0.050 |
Why?
|
| Quality of Life | 2 | 2013 | 12804 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7913 | 0.050 |
Why?
|
| Dendrites | 1 | 2004 | 485 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 941 | 0.050 |
Why?
|
| Centrifugation | 1 | 2000 | 122 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2000 | 149 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2000 | 375 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2002 | 1308 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2000 | 171 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2000 | 213 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3057 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2000 | 224 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2006 | 5179 | 0.040 |
Why?
|
| Xanthines | 1 | 1998 | 121 | 0.040 |
Why?
|
| Anxiety | 1 | 2013 | 4297 | 0.040 |
Why?
|
| Receptors, Purinergic | 1 | 1998 | 66 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1998 | 237 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2000 | 1901 | 0.040 |
Why?
|
| Nerve Net | 1 | 2010 | 2174 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1801 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 3772 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1998 | 643 | 0.040 |
Why?
|
| Phthalimides | 1 | 2017 | 25 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2005 | 1422 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 1144 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 2017 | 374 | 0.040 |
Why?
|
| Remote Sensing Technology | 1 | 2017 | 90 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2005 | 2132 | 0.030 |
Why?
|
| Middle Aged | 7 | 2020 | 213383 | 0.030 |
Why?
|
| Telemetry | 1 | 2017 | 205 | 0.030 |
Why?
|
| Humans | 16 | 2023 | 744343 | 0.030 |
Why?
|
| Computer Communication Networks | 1 | 2017 | 295 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2017 | 221 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2005 | 8436 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 56430 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 21827 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2023 | 1643 | 0.030 |
Why?
|
| Cell Movement | 1 | 2006 | 5217 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 2017 | 442 | 0.030 |
Why?
|
| Models, Biological | 2 | 2017 | 9583 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 6993 | 0.030 |
Why?
|
| Adult | 5 | 2019 | 214055 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2021 | 1248 | 0.030 |
Why?
|
| Mice | 7 | 2007 | 81183 | 0.030 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2013 | 101 | 0.030 |
Why?
|
| Presenilin-1 | 2 | 2006 | 635 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 2505 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2017 | 956 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2017 | 1221 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2021 | 63114 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2012 | 1030 | 0.020 |
Why?
|
| Purines | 1 | 2013 | 594 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 2690 | 0.020 |
Why?
|
| Female | 6 | 2019 | 380194 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2006 | 9734 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2019 | 23403 | 0.020 |
Why?
|
| Universities | 1 | 2013 | 956 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2010 | 18029 | 0.020 |
Why?
|
| Cognition | 1 | 2004 | 6770 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2017 | 2684 | 0.020 |
Why?
|
| Gene Products, tat | 1 | 2006 | 120 | 0.020 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2005 | 30 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2002 | 12072 | 0.020 |
Why?
|
| Patient Preference | 1 | 2013 | 890 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2005 | 121 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12959 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2005 | 129 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2006 | 233 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 6038 | 0.020 |
Why?
|
| Biolistics | 1 | 2004 | 19 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 40075 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2005 | 201 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 964 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2004 | 174 | 0.010 |
Why?
|
| Hydrazines | 1 | 2005 | 226 | 0.010 |
Why?
|
| Cell Survival | 2 | 2006 | 5882 | 0.010 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2002 | 30 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2013 | 1859 | 0.010 |
Why?
|
| Psychometrics | 1 | 2012 | 3002 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
| Rotenone | 1 | 2002 | 43 | 0.010 |
Why?
|
| Ganglia, Sympathetic | 1 | 2002 | 62 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 813 | 0.010 |
Why?
|
| Oxidopamine | 1 | 2002 | 169 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8324 | 0.010 |
Why?
|
| eIF-2 Kinase | 1 | 2002 | 149 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2726 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2088 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6234 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2886 | 0.010 |
Why?
|
| Plaque, Amyloid | 1 | 2004 | 729 | 0.010 |
Why?
|
| Aged | 2 | 2023 | 163280 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2004 | 1100 | 0.010 |
Why?
|
| 14-3-3 Proteins | 1 | 2000 | 214 | 0.010 |
Why?
|
| Protein Folding | 1 | 2002 | 843 | 0.010 |
Why?
|
| Comorbidity | 1 | 2013 | 10388 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 2006 | 7880 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 595 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5892 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2000 | 758 | 0.010 |
Why?
|
| Fear | 1 | 2006 | 1440 | 0.010 |
Why?
|
| Astrocytes | 1 | 2004 | 1270 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2002 | 13033 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4217 | 0.010 |
Why?
|
| DNA Primers | 1 | 2000 | 2892 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2000 | 1185 | 0.010 |
Why?
|
| Learning | 1 | 2004 | 1713 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 4568 | 0.010 |
Why?
|
| Child | 1 | 2020 | 77709 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3507 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2000 | 3748 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11366 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 12797 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2002 | 2775 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7722 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17446 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2002 | 14557 | 0.000 |
Why?
|
| Proteins | 1 | 2000 | 6103 | 0.000 |
Why?
|
| Aging | 1 | 2004 | 8664 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 85781 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9274 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35421 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2000 | 12208 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 29786 | 0.000 |
Why?
|